⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BHVN

Biohaven Ltd.

Healthcare · Biotechnology

15.00USD

+0.2800 (+1.90%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25*Q3 FY25Q2 FY25Q1 FY25Q4 FY24*Q3 FY24
Revenue————————
Cost of Revenue————————
Gross Profit————————
Operating Income-125-130-143-169-212-222-190-178
Net Income-137-131-146-173-198-222-187-160
EPS (Diluted)$-0.91$-0.88$-1.12$-1.64$-1.94$-2.17$-1.78$-1.70

* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)